You are here

  • Home
  • Archive
  • Volume 82, Issue 6
  • Correspondence on ‘Concomitant use of oral glucocorticoids and proton pump inhibitors and risk of osteoporotic fractures among patients with rheumatoid arthritis: a population-based cohort study’

Article info

Article menu

This article has a Reply. Please see:

Download PDFPDF

Correspondence
Correspondence on ‘Concomitant use of oral glucocorticoids and proton pump inhibitors and risk of osteoporotic fractures among patients with rheumatoid arthritis: a population-based cohort study’
Free

Authors

  • Tsung-Kun Lin Department of Pharmacy, Taoyuan Armed Forces General Hospital, Taoyuan, Taiwan School of Pharmacy, National Defense Medical Center, Taipei, Taiwan PubMed articlesGoogle scholar articles
  • Lung-Fa Pan Graduate Institute of Radiological Science, Central Taiwan University of Sciences and Technology, Taichung, Taiwan Department of Cardiology, Taichung Armed Forces General Hospital, Taichung, Taiwan PubMed articlesGoogle scholar articles
  • Gwo-Ping Jong Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan Department of Medicine, Chung Shan Medical University, Taichung, Taiwan PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Gwo-Ping Jong, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung 40201, Taiwan; cgp8009{at}yahoo.com.tw
View Full Text

Citation

Lin T, Pan L, Jong G
Correspondence on ‘Concomitant use of oral glucocorticoids and proton pump inhibitors and risk of osteoporotic fractures among patients with rheumatoid arthritis: a population-based cohort study’
Annals of the Rheumatic Diseases 2023;82:e141.

Publication history

  • Received March 29, 2021
  • Accepted March 30, 2021
  • First published May 26, 2021.
Online issue publication 
May 11, 2023

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.